Cargando…
Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
BACKGROUND: Retrospective studies and single center experiences suggest a role of capecitabine combined with temozolomide (CAPTEM) in neuroendocrine tumors (NENs). METHODS: We performed a systematic review to assess the efficacy and safety of CAPTEM in patients affected with NENs, with the aim to be...
Autores principales: | Arrivi, Giulia, Verrico, Monica, Roberto, Michela, Barchiesi, Giacomo, Faggiano, Antongiulio, Marchetti, Paolo, Mazzuca, Federica, Tomao, Silverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790144/ https://www.ncbi.nlm.nih.gov/pubmed/36575665 http://dx.doi.org/10.2147/CMAR.S372776 |
Ejemplares similares
-
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
por: Thomas, Katharine, et al.
Publicado: (2020) -
Safety and efficacy of combining capecitabine and temozolomide (CAPTEM) to treat advanced neuroendocrine neoplasms: A meta-analysis
por: Lu, Yaoheng, et al.
Publicado: (2018) -
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
por: Roberto, Michela, et al.
Publicado: (2023) -
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021) -
Foreword to the special issue on advances in neuroendocrine neoplasms
por: Vitale, Giovanni, et al.
Publicado: (2021)